The Forensic Accountant nailed the (https://www.cnbc.com/2026/08/05/eli-lilly-lly-earnings-q2-2026.html) on Zepbound momentum—that's real. CVS posted a net margin of with in annual revenue, UNH sits at net margin on in revenue. Both are benefiting from volume on the drug side. But here's the catch: neither company controls the hospital systems that actually *administer* these treatments.

Research these companies